Skip to content

Penumbra PEN Other operating expenses

Other operating expenses at other companies

Medtronic logo
MedtronicMDT
-$260M
Stryker logo
StrykerSYK
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Penumbra’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Penumbra's other operating expenses?
Penumbra (PEN) reported other operating expenses of $215.18M in Q1 2026.
How has Penumbra's other operating expenses changed year-over-year?
Penumbra's other operating expenses increased by 22.6% year-over-year, from $175.53M to $215.18M.
What is the long-term trend for Penumbra's other operating expenses?
Over 4 years (2021 to 2025), Penumbra's other operating expenses has grown at a 11.8% compound annual growth rate (CAGR), from $482.88M to $753.19M.